Evidence map›Paper›PMID 34426606›Full record

ArticleScientific reports2021

Examining cellular responses to reconstituted antibody protein liquids.

M Tyler Nelson, Joseph M Slocik, Eric J Romer, Cassandra I Mankus, Richard T Agans, Rajesh R Naik, Saber M Hussain

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M Tyler Nelson711th Human Performance Wing, Airman Systems Directorate, Air Force Research Laboratory, Wright-Patterson Air Force Base, OH, 45433, USA. nelsonmt05@gmail.com.
Joseph M SlocikMaterials and Manufacturing Directorate, Air Force Research Laboratory, Wright-Patterson Air Force Base, OH, 45433, USA.
Eric J Romer711th Human Performance Wing, Airman Systems Directorate, Air Force Research Laboratory, Wright-Patterson Air Force Base, OH, 45433, USA.
Cassandra I MankusOak Ridge Institute for Science and Education, Oak Ridge, TN, USA.
Richard T AgansThe Henry M. Jackson Foundation, Bethesda, MD, 20817, USA.
Rajesh R Naik711th Human Performance Wing, Airman Systems Directorate, Air Force Research Laboratory, Wright-Patterson Air Force Base, OH, 45433, USA.
Saber M Hussain711th Human Performance Wing, Airman Systems Directorate, Air Force Research Laboratory, Wright-Patterson Air Force Base, OH, 45433, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein ionic liquids (PIL) are a new class of biologic stabilizers designed to protect the functionality and extend the shelf-life of biotechnological and therapeutic agents making them more readily available, and resistant to austere environments. Protein biorecognition elements such as monoclonal antibodies are commonly utilized therapeutics that require the robust stabilization offered by PILs, but biocompatibility remains an important issue. This study has focused on characterizing the biocompatibility of an antibody based PIL by exposing multiple cells types to a cationized immunoglobulin suspended in an anionic liquid (IgG-IL). The IgG-IL caused no significant alterations in cellular health for all three cell types with treatments < 12.5 µg/mL. Concentrations ≥ 12.5 µg/mL resulted in significant necrotic cell death in A549 and HaCaT cells, and caspase associated cell death in HepG2 cells. In addition, all cells displayed evidence of oxidative stress and IL-8 induction in response to IgG-IL exposures. Therapeutic Ig can be utilized with a wide dose range that extends into concentrations we have found to exhibit cytotoxicity raising a toxicity concern and a need for more extensive understanding of the biocompatibility of IgG-ILs.

Indexed as

A549 CellsCell DeathHaCaT CellsHep G2 CellsHumansImmunoglobulin GInterleukin-8Ionic LiquidsOxidantsOxidative StressProtein StabilityImmunoglobulin GInterleukin-8Ionic LiquidsOxidants

Identifiers

PMID34426606
PMCPMC8382709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.